Welltower Inc. (WELL)
| Market Cap | 168.97B +51.8% |
| Revenue (ttm) | 12.76B +37.6% |
| Net Income | 1.55B +37.3% |
| EPS | 2.21 +25.3% |
| Shares Out | 720.74M |
| PE Ratio | 106.26 |
| Forward PE | 80.70 |
| Dividend | $3.40 (1.45%) |
| Ex-Dividend Date | Aug 12, 2026 |
| Volume | 3,982,515 |
| Open | 234.21 |
| Previous Close | 235.63 |
| Day's Range | 232.63 - 237.10 |
| 52-Week Range | 161.26 - 255.20 |
| Beta | 0.76 |
| Analysts | Buy |
| Price Target | 250.27 (+6.75%) |
| Earnings Date | Jul 27, 2026 |
About WELL
Welltower Inc., an S&P 500 company, is positioned at the center of the silver economy, focusing on rental housing for aging seniors across the United States, United Kingdom, and Canada. Their portfolio of 2,500+ seniors and wellness housing communities are positioned at the intersection of housing and hospitality, creating vibrant communities for mature renters and older adults. They believe our real estate portfolio is unmatched, located in highly attractive micro markets with stunning built environments. Yet, Welltower is an unusual real esta... [Read more]
Financial Performance
In 2025, Welltower's revenue was $10.84 billion, an increase of 35.63% compared to the previous year's $7.99 billion. Earnings were $936.85 million, a decrease of -1.56%.
Financial StatementsAnalyst Summary
According to 22 analysts, the average rating for WELL stock is "Buy." The 12-month stock price target is $250.27, which is an increase of 6.75% from the latest price.
News
Welltower price target raised to $260 from $235 at Cantor Fitzgerald
Cantor Fitzgerald raised the firm’s price target on Welltower (WELL) to $260 from $235 and keeps an Overweight rating on the shares. Healthcare REIT results highlight strong Senior Housing Operating…
Welltower price target raised to $275 from $255 at Citi
Citi analyst Nick Joseph raised the firm’s price target on Welltower (WELL) to $275 from $255 and keeps a Buy rating on the shares.
Welltower price target raised to $260 from $236 at Evercore ISI
Evercore ISI analyst James Kammert raised the firm’s price target on Welltower (WELL) to $260 from $236 and keeps an Outperform rating on the shares.
Welltower Earnings Call Transcript: Q2 2026
Record quarter with 25% FFO growth, robust senior housing demand, and strong margin expansion led to raised full-year guidance. Over $15B in investments year-to-date, disciplined capital allocation, and a 15% dividend increase highlight confidence in long-term growth.
Welltower Earnings release: Q2 2026
Welltower released its Q2 2026 earnings on July 28, 2026, summarizing the period's financial results.
Welltower Slides: Q2 2026
Welltower has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 28, 2026.
Welltower Quarterly report: Q2 2026
Welltower has published its Q2 2026 quarterly earnings report on July 28, 2026.
Welltower raises FY26 normalized FFO view to $6.36-$6.44 from $6.21-$6.35
Consensus is for FY26 FFO $6.32. Sees FY26 blended SSNOI growth of 13.75%-16.00%, which is comprised of the following components: Seniors Housing Operating approximately 18.5% to 21.5%; Seniors Housin...
Welltower reports Q2 EPS 61c, consensus 65c
Reports Q2 revenue $3.54B, consensus $3.39B. Reports Q2 total portfolio year-over-year sameSSNOI growth of 15.5%, driven by SSNOI growth in SHO portfolio of 20.5%
Welltower reports Q2 normalized FFO $1.60, consensus $1.55
16:14 EDT Welltower (WELL) reports Q2 normalized FFO $1.60, consensus $1.55
Welltower Issues Business Update
TOLEDO, Ohio, July 27, 2026 /PRNewswire/ -- Welltower® Inc. (NYSE: WELL) has issued the following business update which can be found at: https://welltower.com/jul-27-26-business-update About Welltowe...
Welltower Reports Second Quarter 2026 Results
TOLEDO, Ohio, July 27, 2026 /PRNewswire/ -- Welltower Inc. (NYSE:WELL) today announced results for the quarter ended June 30, 2026. Second Quarter and Other Recent Highlights Reported net income attri...
Welltower price target raised to $260 from $239 at Mizuho
Mizuho raised the firm’s price target on Welltower (WELL) to $260 from $239 and keeps an Outperform rating on the shares. The firm adjusted targets in the healthcare real estate…
Welltower price target raised to $271 from $249 at UBS
UBS analyst Michael Goldsmith raised the firm’s price target on Welltower (WELL) to $271 from $249 and keeps a Buy rating on the shares.
Welltower initiated with an Equal Weight at Barclays
Barclays initiated coverage of Welltower (WELL) with an Equal Weight rating and $254 price target While initiating coverage of six healthcare REITs, the analyst tells investors that healthcare real es...
He Dared to Buy Senior Housing at Its Lows. Now He Runs a $160 Billion Empire.
Welltower's CEO received an enormous pay package for the company's turnaround, which has drawn shareholder backlash.
Welltower Announces Date of Second Quarter 2026 Earnings Release, Conference Call and Webcast
TOLEDO, Ohio, June 23, 2026 /PRNewswire/ -- Welltower® Inc. (NYSE: WELL) today announced it will release second quarter 2026 financial results after the close of trading on the New York Stock Exchange...
Welltower CFO's $167 Million Pay Package Sets New Record
Finance chief Tim McHugh's pay outpaces that of many CEOs and surpasses the Tesla CFO's $139 million pay package in 2024.
Welltower price target lowered to $232 from $248 at Scotiabank
Scotiabank lowered the firm’s price target on Welltower (WELL) to $232 from $248 and keeps an Outperform rating on the shares. The firm sees real estate investment trust valuations as…
WELL Health Announces Voting Results for Election of Directors
Vancouver, British Columbia--(Newsfile Corp. - June 17, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital health company focused on positively impa...
Welltower resumed with an Outperform at Raymond James
Raymond James analyst David Rodgers resumed coverage of Welltower (WELL) with an Outperform rating and $226 price target The firm sees investor focus shifting from Welltower’s from investments to its…
WELL Health Provides a Corporate Update on Circle Medical
WELL Health is providing a corporate update on its majority-owned subsidiary Circle Medical, a leading telehealth platform delivering accessible, insurance-based primary care across the United States....
Ecolab added to ‘US 1 List’ at BofA
BofA added Ecolab (ECL) to the firm’s “US 1 List,” a collection of its best investment ideas. The firm is also renewing Nvidia (NVDA) and Welltower (WELL) after 52 weeks…
Welltower raises quarterly dividend 15% to 85c per share
Welltower (WELL) announced that it expects to raise its quarterly common stock dividend to 85c per share, beginning with the second quarter of 2026. The declaration and payment of any…
Welltower Board of Directors Approves 15% Increase in Quarterly Dividend to $0.85 per Share
TOLEDO, Ohio, June 1, 2026 /PRNewswire/ -- Welltower Inc. (NYSE: WELL) ("Welltower" or the "Company") today announced that it expects to raise its quarterly common stock dividend to $0.85 per share, b...